Ophthalmology, Malmö

Organisational unit: Division

Research areas and keywords

UKÄ subject classification

  • Ophthalmology
  • Endocrinology and Diabetes


  • glaucoma, endocrinology, diabetes, ocular hypertension, perimetry, visual dysfunction, endocrine ophthalmopathy


Glaucoma is the 2nd most common cause of blindness. Subjective symptoms are typically not perceived until late in the disease course, but glaucoma patients are at greater risk for falls and auto accidents. Elevated intraocular pressure (IOP) is the strongest known risk factor for developing glaucoma, but only elevated IOP without glaucoma damage is at least twice as common as manifest glaucoma, and half of all glaucoma patients have normal IOP. All current treatment aims at reducing IOP and thereby prevents fast deterioration of the visual field, which can lead to visual impairment. The speed of visual field deterioration varies very much among patients. In clinical practice intervention decisions should be based on the rate of progression, yet clinical decisions are often based mainly on IOP leading to a considerable under- and over- treatment. The aim of our research is to provide a better scientific basis for glaucoma management, and to better prioritize health care.

Recent research outputs

Vergmann, A. S., Broe, R., Kessel, L., Jesper Leth Hougaard, Möller Christensen, Sören, S., Kyvik, K. O., Larsen, M., Munch, I. C. & Grauslund, J. 2017 In : Investigative Ophthalmology and Visual Science. 58, 10, p. 3997-4002 6 p.

Research output: Contribution to journalArticle

View All (203)